Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH‐MYCN transgenic mice

Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH‐MYCN transgenic mice

Abstract Neuroblastoma is a highly aggressive pediatric cancer with a poor prognosis, particularly in high‐risk (HR) cases characterized by MYCN amplification. The severe side effects associated with high‐dose chemotherapy further complicate treatment. Despite significant advancements in drug screen...

Full description

Saved in:
Bibliographic Details
Main Authors: Yen‐Tzu Liao, Zhi‐Kai Yu, Yi‐Xun Huang, Kuan‐Hung Lin, Ching‐Te Kuo, Tsai‐Shan Yang, Pei‐Yi Wu, Chi‐Tai Yeh, Yen‐Lin Liu, Chien‐Chin Chen, Chiung‐Nien Chen, Wen‐Ming Hsu, Hsinyu Lee
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Bioengineering & Translational Medicine
Subjects:
BioNDP
chemotherapy
drug screening
neuroblastoma
synergy
TH‐MYCN mice
Online Access:https://doi.org/10.1002/btm2.70007
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/btm2.70007

Similar Items